Reference Source

Holle Baby Food GmbH · 99-39 · SWITZERLAND

For Holle Baby Food GmbH · 99-39 · SWITZERLAND, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is SWITZERLAND; product is Holle Organic Infant Follow-On Formula 2 | Anfangs-milch 1 (infant formula); product code is 40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula | 40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula; date published is 10/31/2016; address is Lorracherstrasse 50 , Riehen, Basel Town SWITZERLAND, verified against its source on 2026-09-16.

Firm
Holle Baby Food GmbH verified
Import alert
99-39
Import alert name
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Country
SWITZERLAND verified
Address
Lorracherstrasse 50 , Riehen, Basel Town SWITZERLAND verified
Date published
10/31/2016 verified
Product code
40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula | 40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula each item verified
Product
Holle Organic Infant Follow-On Formula 2 | Anfangs-milch 1 (infant formula) each item verified
FDA notes
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act in that the business association to the product is not declared as required in 21 CFR 101.5(c). Specifically, the business addresses provided lack the name of the country. Section 403(e)(2) of the Act in that the label appears to lack the net quantity of contents statement in avoirdupois pound and ounces on the principal display panel in accordance with 21 CFR 101.105. The ingredient list appears to include the intervening material, "Germany" (21 CFR 101.2(e)). Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4. For example, it appears that the foreign spelling of the words "zinc sulphate," "copper sulphate," "manganese sulphate," and "demineralised." is used. Additionally, the label appears to refer to this infant formula product as "milk" in several places. This infant formula product should not be referred to as "milk." | The article is subject to refusal of admission pursuant to section 801(a) (3) in that it appears to be misbranded within the meaning of Section 403(f) of the Act in that the label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1). Also; the labels appear to not comply with the requirements of 21 CFR 101.5; in part; because it appears that the business address lacks the name of the country. We further note that a statement of the country of manufacturer has little bearing on the requirements of 21 CFR 101.5. The labels appear to not comply with the requirements of 21 CFR 101.105. The net quantity of contents is not on the PDP or in the U.S. customary units. In addition; the firm should be advised that for products represented for use as an infant formula; Section 412 of the Federal Food; Drug; and Cosmetic Act requires persons responsible for the manufacture or distribution of infant formula to register and submit certain information to FDA. Failure to comply with these provisions is a prohibited act under section 301(s) of the FD&C Act. Products represented for use as an infant formula must comply with the labeling provisions of 21 CFR Part 107. Failure to comply with these regulations causes the products to be misbranded under section 403(a)/201(z) of the FD&C Act. Section 412 (a) of the Act stipulates that an infant formula is deemed adulterated if the processing of such infant formula is not in compliance with the good manufacturing practices and quality control procedures found in Title 21 of the Code of Federal Regulations Part 106. each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Holle Baby Food GmbH Date Published : 10/31/2016 Lorracherstrasse 50 , Riehen, Basel Town SWITZERLAND 40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula Date Published: 04/14/2017 Desc: Holle Organic Infant Follow-On Formula 2 Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act in that the business association to the product is not declared as required in 21 CFR 101.5(c). Specifically, the business addresses provided lack the name of the country. Section 403(e)(2) of the Act in that the label appears to lack the net quantity of contents statement in avoirdupois pound and ounces on the principal display panel in accordance with 21 CFR 101.105. The ingredient list appears to include the intervening material, "Germany" (21 CFR 101.2(e)). Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4. For example, it appears that the foreign spelling of the words "zinc sulphate," "copper sulphate," "manganese sulphate," and "demineralised." is used. Additionally, the label appears to refer to this infant formula product as "milk" in several places. This infant formula product should not be referred to as "milk." 40 P - - 01 Milk Base Infant Formula Product (0-12 months), Powder Formula Date Published: 10/31/2016 Desc: Anfangs-milch 1 (infant formula) Notes: The article is subject to refusal of admission pursuant to section 801(a) (3) in that it appears to be misbranded within the meaning of Section 403(f) of the Act in that the label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1). Also; the labels appear to not comply with the requirements of 21 CFR 101.5; in part; because it appears that the business address lacks the name of the country. We further note that a statement of the country of manufacturer has little bearing on the requirements of 21 CFR 101.5. The labels appear to not comply with the requirements of 21 CFR 101.105. The net quantity of contents is not on the PDP or in the U.S. customary units. In addition; the firm should be advised that for products represented for use as an infant formula; Section 412 of the Federal Food; Drug; and Cosmetic Act requires persons responsible for the manufacture or distribution of infant formula to register and submit certain information to FDA. Failure to comply with these provisions is a prohibited act under section 301(s) of the FD&C Act. Products represented for use as an infant formula must comply with the labeling provisions of 21 CFR Part 107. Failure to comply with these regulations causes the products to be misbranded under section 403(a)/201(z) of the FD&C Act. Section 412 (a) of the Act stipulates that an infant formula is deemed adulterated if the processing of such infant formula is not in compliance with the good manufacturing practices and quality control procedures found in Title 21 of the Code of Federal Regulations Part 106.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.